VSTM

Verastem, Inc. Press Releases

$7.96
*  
0.34
4.1%
Get VSTM Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading VSTM now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Verastem Presents Results and Updated Development Plans at Annual Research and Development Day
7/10/2014 4:01:00 PM - Business Wire

Verastem, Inc. (NASDAQ: VSTM) to Ring The NASDAQ Stock Market Closing Bell
7/9/2014 10:00:00 AM - GlobeNewswire

Verastem to Ring the NASDAQ Stock Market Closing Bell and Host Annual Research and Development Day on July 10, 2014
7/8/2014 7:00:00 AM - Business Wire

The Potential of Targeting Cancer Stem Cells Through FAK Inhibition in Mesothelioma Reported in AACR’s Cancer Discovery
6/24/2014 7:00:00 AM - Business Wire

Verastem Announces Annual Research and Development Day and Webcast
6/18/2014 7:00:00 AM - Business Wire

Verastem to Present at Upcoming Conferences
6/10/2014 7:00:00 AM - Business Wire

Verastem Presents Updated Clinical Data from VS-6063 and Paclitaxel Combination Phase 1/1b Study in Patients with Ovarian Cancer at the 2014 ASCO Annual Meeting
6/2/2014 7:00:00 AM - Business Wire

Verastem Publishes Scientific Data on Targeting Mesothelioma Cancer Stem Cells in Science Translational Medicine
5/27/2014 7:00:00 AM - Business Wire

Verastem to Present at the 2014 ASCO Annual Meeting
5/20/2014 7:00:00 AM - Business Wire

Verastem to Present at Upcoming Investor Conferences
5/14/2014 7:00:00 AM - Business Wire

Dr. Paul A. Friedman Joins Verastem Board of Directors
5/12/2014 4:00:00 PM - Business Wire

Verastem Announces Initiation of COMMAND Study in Japan
5/12/2014 7:00:00 AM - Business Wire

Verastem Reports First Quarter 2014 Financial and Corporate Results
5/8/2014 4:14:00 PM - Business Wire